3,4-Dihydro-2H-pyran-5-carbaldehyde, 95.0%, 100mg

3-Tetrazol-1-yl-1H-pyrazole-4-carboxylic acid, 95.0%, 5g

2-(2-Pyrrolidin-1-ylethoxy)ethylamine, 98.0%, 5g

2-mercapto-4-(4-methoxyphenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydroquinoline-3-carbonitrile, 95.0%, 500mg

4-Chloro-2,6-dimethylpyrimidine, 97.0%, 25g

(R)-2-(Fluoromethyl)morpholine hydrochloride, 98%, 100mg

3-Bromo-4-nitrobenzoic Acid>98.0%(GC)(T)1g

Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-7-carboxylate, 95.0%, 250mg

1,5-Dichloropentan-3-one, 95.0%, 100mg

N-4-Boc-2-Piperazinecarboxylic acid methyl ester, 95.0%, 5g

Colonna capillare per GC ROTI®Cap-1, 25 m, 0.53 mm, 0.50 µm, 1 Pezzo(i)

Glycidyl 4-methoxyphenyl ether, 95.0%, 500g

2-ethynylpyrrolidine hydrochloride, 95.0%, 1g